Literature DB >> 15068570

Fatal overdosage with cisplatin.

C Charlier1, P Kintz, N Dubois, G Plomteux.   

Abstract

This paper presents a case of fatal overdosage due to an accidental massive administration (750 mg instead of 170 mg) of cisplatin, an anticancer agent, to a 63-year-old patient suffering from lymphoma. Platinum was measured in various postmortem samples by means of inductively coupled plasma mass spectrometry. Heart and peripheral blood concentrations of platinum were 1515 and 1253 micro g/L, respectively. Concentrations in urine and bile were 1038 and 501 micro g/L, respectively. Renal dialysis was started immediately after the end of cisplatin perfusion, when the mistake was noticed, but the patient deceased at day 16, presenting renal and hepatic insufficiency, ototoxicity, and pancytopenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068570     DOI: 10.1093/jat/28.2.138

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  9 in total

1.  Cisplatin Concentrations in Long and Short Duration Infusion: Implications for the Optimal Time of Radiation Delivery.

Authors:  Pradeep Rajkumar; Binu Susan Mathew; Saikat Das; Rajesh Isaiah; Subashini John; Ratna Prabha; Denise Helen Fleming
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Cancer cells that survive checkpoint adaptation contain micronuclei that harbor damaged DNA.

Authors:  Cody W Lewis; Roy M Golsteyn
Journal:  Cell Cycle       Date:  2016-09-16       Impact factor: 4.534

3.  Successful treatment of Cisplatin overdose with plasma exchange.

Authors:  Yasuhiro Yamada; Yoshiaki Ikuta; Kisato Nosaka; Nobutomo Miyanari; Naoko Hayashi; Hiroaki Mitsuya; Hideo Baba
Journal:  Case Rep Med       Date:  2010-03-11

Review 4.  Cisplatin overdose: toxicities and management.

Authors:  Roger Y Tsang; Turki Al-Fayea; Heather-Jane Au
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.

Authors:  Guenter Hofmann; Thomas Bauernhofer; Peter Krippl; Doris Lang-Loidolt; Sabine Horn; Walter Goessler; Walter Schippinger; Ferdinand Ploner; Herbert Stoeger; Hellmut Samonigg
Journal:  BMC Cancer       Date:  2006-01-04       Impact factor: 4.430

Review 6.  Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis.

Authors:  Tzewah V Leung; Mitchell E Hughes; Christine G Cambareri; Daniel J Rubin; Beth Eaby-Sandy
Journal:  J Adv Pract Oncol       Date:  2018-09-01

Review 7.  Therapeutic Plasma Exchange: For Cancer Patients.

Authors:  Yuru Hu; Hanshan Yang; Shaozhi Fu; Jingbo Wu
Journal:  Cancer Manag Res       Date:  2022-02-02       Impact factor: 3.989

8.  Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines.

Authors:  Maciej Sobczak; Magdalena Strachowska; Karolina Gronkowska; Agnieszka Robaszkiewicz
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 9.  Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells.

Authors:  Lucy H Swift; Roy M Golsteyn
Journal:  Int J Mol Sci       Date:  2014-02-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.